On April 25, 2025, Shanghai Escugen Biotechnology Co., Ltd. and ConjugateBio Inc., based in the United States, jointly announced the signing of an exclusive option agreement for the EZWi-Fit® platform technology.

On March 13, 2025, the much-anticipated BIOCHINA 2025 (10th) International Convention kicked off at the Suzhou International Expo Center. The results of the BIOCHINA Awards 2024 were grandly announced at this expo. Shanghai Escugen Biotechnology Co., Ltd. was honored to be listed on the BIOCHINA Awards 2024 —— "Top 100 Innovative Breakthrough Enterprises" for its outstanding performance and great potential in the bio-pharmaceutical innovation and research field.